A Phase III, Multicenter, Randomized, Evaluator-blinded, Parallel-Group, Active-controlled Clinical Trial to Evaluate the Efficacy and Safety of Ciprofloxacin 0.3% Plus Fluocinolone Acetonide 0.025% Otic Solution in the Treatment of Acute Otitis Externa (AOE)
Latest Information Update: 05 Oct 2022
At a glance
- Drugs Ciprofloxacin/fluocinolone acetonide (Primary) ; Ciprofloxacin
- Indications Otitis externa
- Focus Therapeutic Use
- Sponsors Lee's Pharmaceutical
- 23 Nov 2020 New trial record